Top Trends in Anti-Hypertensive Drugs Market 2017- Design Competition Strategies by Identifying Who-Stands-Where in the Market SUMMARY MarketResearchFuture published new report, titled “Anti-Hypertensive Drugs- Market Research
Report: Forecast to 2022”. Market Synopsis of Global Anti-Hypertensive Drugs Market: Market Scenario: Anti-hypertensive drugs are used to treat hypertension (high blood pressure). Hypertension is a state of chronic elevated arterial blood pressure at or greater than 140/90 mm Hg for adults. The global anti-hypertensive drugs market was valued at $32.2 billion in 2015, and is expected to reach $ 38.9 billion by 2022. Thus the market is expected to perform sluggish growth at a CAGR of 2.73% from 2016 to 2022. There exact cause of essential hypertension is unknown but is blamed on unhealthy lifestyle and ageing. The major market driving factor for secondary hypertension are greater detection and early diagnosis. Rise in the prevalence diseases such as kidney problems, thyroid problems, adrenal gland tumors, heart ailments, chronic alcohol use etc. in which anti-hypertensive are used are some of the other factors driving the growth of the market. The constraints however are overwhelming and include patent expiries such as Actelion's Tracleer (2015), and United Therapeutic's Remodulin (2014). Other blockbuster’s such as Novartis's Diovan and Exforge, Sanofi Aventis's Avapro (2012) etc are also off-patent.
Key Players for Global Anti-Hypertensive Drugs Market: Novartis AG, Daiichi Sankyo Company Limited, Acetelion Ltd, Boehringer Ingelheim, Sanofi S.A., Astra Zeneca plc, Ranbaxy Laboratories Limited, Inc., Takeda Pharmaceuticals Company Limited, Pfizer Inc.
Segments: Global anti-hypertensive drugs market has been segmented on the basis of pharmacological class, hypertension type, disease source and Region.
GET SAMPLE REPORT @ https://www.marketresearchfuture.com/sample_request/2347 Regional Analysis of Global Anti-Hypertensive Drugs Market: Globally North America is the largest market for global anti-hypertensive drugs. Europe is the second-largest market for global anti-hypertensive drugs. The near future market for antihypertensive drugs will be dominated by the developed regions with developing regions providing a supporting role only. However the developing regions market particularly Asia Pacific will be the fastest growing and is likely to be the key to the future. The report for Global Anti-Hypertensive Drugs Market of Market Research Future comprises